Plus   Neg

McKesson Boosts FY21 Adj. EPS Outlook; Authorizes $2 Bln Share Buyback - Quick Facts

While reporting financial results for the third quarter on Tuesday, McKesson Corp. (MCK) raised its adjusted earnings guidance for the full-year 2021 to reflect improved growth in the business and the contribution from its successful distribution of COVID-19 vaccines and ancillary supplies.

For fiscal 2021, the company now projects adjusted earnings in a range of $ $16.95 to $17.25 per share, up from the previous guidance range of $16.00 to $16.50 per share.

On average, analysts polled by Thomson Reuters expect the company to report earnings of $16.42 per share for the year. Analysts' estimates typically exclude special items.

Additionally, McKesson's Board of Directors authorized an additional $2.0 billion share repurchase program, demonstrating confidence in McKesson's diversified capital allocation strategy.

For comments and feedback contact: editorial@rttnews.com

Business News

Editors Pick
Intel Corp's Mobileye and self-driving delivery startup Udelv have signed a deal to launch a fully driverless delivery service in the United States by 2023. The companies plan to produce more than 35,000 Mobileye-driven Transporters by 2028. Domino's Pizza and autonomous vehicle startup Nuro are launching autonomous pizza delivery in Houston, this week. Some Domino's customers in Houston can have a pizza delivered by Nuro's R2 robot. CVS Health is now offering cost COVID-19 vaccines at select CVS Pharmacy locations in four more U.S. states as part of its ongoing effort to expand access to COVID-19 vaccines. It has now expanded the program to 51 more select locations in Arkansas, Nebraska, Iowa and Maine. It began in Washington, West Virginia, Delaware and New Mexico at 15 select locations from March 31.
Follow RTT